Abstract-This paper presents a dual-recognition model of the T-cell receptor that has been constructed to account for the phenomenon of MHC restriction as well as the paradoxical ability of T-cells to be both multispecific and precisely specific at the same time. In our model the combining sites for antigen and MHC are not independent as in classical dual-recognition models. but interact with each other by an allosteric mechanism. We envision a flexible receptor with combining sites for antigen and MHC that are capable of existing in a multitude of distinct complementarity states. MHC and antigen molecules act as allosteric effectors such that one ligand perturbs the conformation and therefore the specificity of the site for the other ligand. An essential feature of the model is that different MHC determinants induce different conformations at the anti-antigen site. In this way the receptor acquires multiple specificities. Within a particular complementarity state, precise recognition results from the requirement that antigen and MHC exhibit positive cooperativity in their binding to the T-cell receptor. Positive cooperativity is also the basis for MHC restriction. Reaction mechanisms are presented which describe the requirement that antigen and MHC both induce conformational changes in order to generate high-affinity binding to either ligand. As a precedent for the multistate allosteric receptor model, we discuss the properties of allosteric enzymes, especially ribonucleotide reductase, whose properties are analogous to those we have postulated for the T-cell receptor. Also discussed is the possibility that molecules such as Ly2, L3T4 and the MIs antigen, which have been found to playa role in antigen recognition, function as affinity-enhancing allosteric effectors that interact with the constant portion of the T-cell receptor.
INTRODUCTION
One of the most controversial issues in contempor ary immunology is the nature of the T-cell receptor -for antigen. In spite of intensive investigations for more than a decade, the nature of the T-cell receptor remains obscure. Virtually all aspects of the problem have generated unresolved contro versy. At the center of this controversy is the phenomenon of MHC restriction. In marked .con trast to B-cells, major classes of T-cells do not functionally recognize isolated conventional antigen (A) molecules. Rather, A is only recognized in association with self MHC molecules (Kindred and Shreffler, 1972; Rosenthal and Shevach, 1973; Zinkernagel and Doherty, 1974a; Miller et at., 1975; Cohn and Epstein, 1977) . Several ingenious theor etical models have been constructed to account for this phenomenon (Katz et at., 1973; Zinkernagel and Doherty, 1974a, b; Blanden et at., 1976c Blanden et at., , 1980 Janeway et at., , 1980a Blanden and Ada, 1978; Langman, 1978; Cohn and Epstein, 1978; Bena cerraf, 1978; Schrader, 1979; Williamson, 1980; Droge, 1981; Eichmann, 1981 ; Reinherz et at., 1983; Swain et at., 1983) . Most of these models fall into * We dedicate this paper to Dr E. A. Kabat and to his first graduate student, the late Dr Sam M. Beiser, both of whom greatly influenced the course of research in this laboratory. This research was supported by NIH Grant AI-17949.
two categories: single-recognition models which postulate the existence of neoepitopes that arise as a result of an interaction between A and MHC molecules, and dual-recognition models which postulate the existence of separate receptors for A and MHC molecules or else the existence of independent sites on a single receptor. While im pressive data have been marshalled in support of both types of models, it is our view that none of the proposed theories are fully consistent with all of the data that can be considered to be well-established. We have therefore been led to reconsider the T-cell receptor problem in the context of MHC restriction. In this communication, we propose a new type of dual-recognition model which envisions a flexible receptor capable of assuming many different con formational states. We present this model in the hope that it may be useful in understanding the biochemical data that are beginning to emerge from the application of the recombinant DNA and mono clonal antibody technologies to the T-cell receptor problem.
PARADOXICAL ASPECTS OF T·CELL A SPECIFICITY
The construction of this model has been carried out not only to account for MHC restriction but also to explain a paradoxical aspect of T-cell antigen specificity. A number of studies have shown that MHC-restricted T-cells are capable of recognizing A-MHC combinations in an exquisitely specific fashion. In these studies, it was found that a change of one or two residues in the amino acid sequence of either A or MHC caused a loss of recognition (Keck, 1975; Zinkernagel, 1976; Maizels et al., 1980; Whitmore and Gooding, 1981; DeWaal et al., 1983; Townsend et al., 1983a, b; Berkower et al., 1984; Lin et al., 1984) . Other studies have indicated that hapten-specific T-cells' are also capable of recognizing subtle differences in hapten structures (Gell and Silverstein, 1962; Silverstein ?nd Gell, 1962; Janeway et al., 1975 Janeway et al., , 1976a Levy and Shearer, 1982; Rao et al., 1984) .
Although some studies (Simpson et al., 1978; Nagy and Elliot, 1979; Janeway et al., 1982) have indicated that alloreactive T-ct.-lIs are more cross reactive than self-MHC restricted T-cells, other studies (Melief et al., 1980; Sherman, 1982; DeWaal et al., 1983) with MHC mutants have suggested that this is due to the antigenic complexity of MHC molecules, rather than to a lack of specificity. In particular, studies at the clonal level have indicated that single amino acid substitutions can cause loss of recognition (Sherman, 1982) . Thus, alloreactive T cells are also capable of highly specific recognition of conformational nuances.
The aforementioned body of data which are based on studies of both populations and single clones of T-cells leads to the conclusion that T-cells are capable of recognizing antigen with great precision. There is, however, another growing body of data which give quite a different impression. A number of clones, initially selected for specificity to A + self MHC have also been found to possess alloreactivity, i.e. A + self MHC = allo MHC (Bevan, 1977; Billings et al., 1977; Burakoff et al., 1978; von Boehmer et al., 1979; Brachiale et al., 1981; Askonas and Lin, 1982; Guimezanes et al., 1982a, b; Hurtenbach et al., 1983; Abromson-Leeman and Cantor, 1983) . In these cases, the MHC molecules differ by a large number of amino acids. A is either eliminated or, as some have suggested (Matzinger and Bevan, 1977) , replaced by some endogenous non-polymorphic A on the target cell that is likely to have a very different amino acid sequence. Thus recognition is preserved in spite of large changes in A and MHC. Taken in isolation, this body of data could be construed as evidence for a high degree of multispecificity and therefore a lack of precision in antigen recognition.
Another approach, based on limiting-dilution methods, has also produced data that point to a high degree of T-cell multispecificity. It has been found that precursor T-cells specific for determinants on typical A (e.g. Strep. A, TNP and SRBC) occur at a frequency of about 1% (Eichmann et al., 1982; Fey et al., 1983) . Given the large diversity of As, this surprisingly high precursor frequency, which is substantially higher than B-cell precursor fre quencies, implies a high degree of multispecificity in T-cell A recognition.
How is it possible that T-cells can be precisely specific and multispecific at the same time? Eich mann et al. (1982) have suggested that the apparent precision of T-cell antigen recognition seen in some studies is not due to intrinsic properties of the T-cell receptor, but is rather a property of populations of T-cells that arises as a result of regulation. This argument cannot be immediately excluded for earlier studies which assayed populations of cells. However, a substantial number of more recent studies which demonstrate precise recognition have employed T-cell clones. In these cases it is reason able to assume that the observed specificity is a reflection of the intrinsic specificity of the T-cell receptor. It thus appears that the simultaneous juxtaposition of precise specificity and multispeci ficity is a genuine paradox that must be resolved.
Our approach to resolving this paradox is based on the findings of Bevan (1981, 1982) , who have isolated clones having a dual specificity of the form Al + MHCl = A2 + MHC2. Cold target inhibition studies have shown that a single receptor recognizes both A-MHC combinations. If this dual specificity is interpreted in the context of a single recognition model, it becomes necessary to assume that the two A-MHC combinations generate neo epitopes that are cross-reactive relative to the single specificity of the receptor. Since little is currently known about the rules of neoepitope formation, it is difficult to pursue this line of interpretation further. However, if the dual specificity is interpreted in the context of a dual-recognition model, several import ant conclusions can be deduced. First, it might be expected that the dual specificity results from cross reactivity of Al and A2 relative to the anti-A site and cross-reactivity of MHCl and MHC2 relative to the anti-MHC site. Given the known multispecificity of T-cells it is conceivable that Al or A2 could bind to the anti-A site in spite of a poor fit, or that the anti-A site contains distinct subsites that react with Al and A2. Similar expectations would also apply to the anti-MHC site. This explanation predicts that the cross-permutations Al + MHC2 and A2 + MHCl should also be recognized. However, Bevan (1981, 1982) have shown that they are not recognized. This rules out the "poor-fit" and "subsite" interpretations, and suggests that T-cell multispecificity cannot be equated with poor speci ficity.
The failure to recognize the cross-permutations also has additional implications for dual-recognition models. Classical dual-recognition models envision either separate anti-A and anti-MHC receptors or else independent sites on a single receptor. These models clearly predict that the cross-pennutations described earlier should be recognized. That they are not seems to rule out these models. The firmness of this conclusion is further established by the findings of Kappler et al. (1981) . Using hybrid T cells having two distinct specificities (i.e. Al + MHC1 *-A2 + MHC2) they have also found that the cross-permutations are not recognized. In ad dition, Harris et al. (1984) have made similar observations with T-cells having hybrid membranes.
Given that classical dual-recognition models are ruled out, it might be concluded that available data are best explained with a single-recognition model. While single-recognition models are consistent with the data, it should be stressed that dual-recognition models with interacting sites, Le. non-independent sites, are not ruled out.
In addition to being incompatible with the non recognition of the cross-permutations described earlier, classical dual-recognition models appear unable to provide a framework in which to resolve the apparently paradoxical juxtaposition of precise specificity and multispecificity. A tacit assumption of classical dual-recognition models is that A and MHC molecules interact with their binding sites according to "lock-and-key" principles. This is tantamount to assuming a rigid receptor (Koshland, 1958) and, in the context of a rigid receptor, it seems inevitable that multispecificity be equated with poor specificity. However, it appears that the paradoxical aspects of T-cell antigen specificity can be resolved in the context of a flexible receptor. By a flexible receptor, we mean a receptor which can exist in several different conformations that represent dis tinct complementarity states. The multispecificity of the T-cell receptor is· explained by the existence of multiple complementarity states, while the fine specificity data are accommodated by assuming that, within a given complementarity state, antigen recog nition is exquisitely specific. A flexible receptor is also required if the sites are to interact with and perturb each other. Otherwise, it would not be possible for the binding of a ligand at one site to alter the conformation of the other site. In what follows we attempt to show that a two-site receptor capable of assuming many conformational states that are allosterically controlled by A and MHC ligands is consistent with available data.
The construction of the multistate allosteric re ceptor model must accommodate four constraints:
(1) A recognition is MHC-restricted.
(2) A recognition is multispecific and precisely specific at the same time.
(3) Recognition at the anti-A site is not indepen dent of recognition at the anti-MHC site.
(4) The combining sites of T-cell receptors con tain variable regions which are expressed in a clonal fashion.
With these in mind, we present the following postulates.
Postulate 1
The T-cell receptor is an allosteric receptor that can simultaneously interact with two allosteric effector ligands: one ligand is a determinant on an MHC molecule and the other is a determinant on an A molecule.
We first consider interactions between the T-cell receptor and MHC molecules. Since the T-cell receptor has one or more variable regions, we refer to it in what follows as a "V-molecule". A basic requirement imposed by the phenomenon of MHC restriction is that T-cells (i.e. mature peripheral T cells) are not activated by recognition of self MHC. In other words, binary complexes between V molecules and self MHC molecules do not trigger T cells. On the other hand, if MHC molecules are to be allosteric effectors of V-molecules, it is necessary that V-molecules have at least a moderate affinity for self MHC determinants. We are thus led to the following postulates.
Postulate 2a. For every V-molecule expressed by a T-cell clone, there exists a determinant on some self
assumed to be an affinity threshold, above which the T-cell will be triggered, and K p is an affinity threshold above which the allosteric effector can induce a significant conformational change in V. For convenience, we will speak of three ranges of
and high affinity, where K > K t • For simplicity, we neglect the fact that triggering probabilities will also depend on the concns of A, MHC and V-molecules (Matis et al., 1982 (Matis et al., , 1983 . Postulate 2b. MHC restriction is a binding-event phenomenon in which: (a) binary complexes of high affinity do not form with self A, self MHC or with non-self A molecules, and (b) high-affinity binding, i.e . .functionally significant binding to non-self A molecules, occurs only when a ternary A:V:M complex forms.
DESCRIPTION OF THE NOMENCLATURE FOR COMPLEMENTARITY STATES OF V-MOLECULES
As specified in postulate 1, A and MHC mol ecules are allosteric effectors of V-molecules. It is thus necessary to describe the complementarity states of V-molecules that can arise by interactions with A and MHC molecules. Since two ligands can simultaneously influence conformation allosterically (postulate 1), two indices are needed. Let V oo denote the complementarity state of V when it is unperturbed by either MHC or A. Let Yom rep resent the complementarity state (an equilibrium conformational state) induced by interaction with a particular determinant on an MHC molecule, in the absence of binding to A. Similarly, we let V ao denote the complementarity state induced by a particular determinant on an A molecule, in the absence of binding to MHC. If these determinants fashion. In these studies, it was found that a change of one or two residues in the amino acid sequence of either A or MHC caused a loss of recognition (Keck, 1975; Zinkernagel, 1976; Maizels et al., 1980; Whitmore and Gooding, 1981; DeWaal et al., 1983; Townsend et al., 1983a, b; Berkower et al., 1984; Lin et al., 1984) . Other studies have indicated that hapten-specific T-cells are also capable of recognizing subtle differences in hapten structures (Gell and Silverstein, 1962; Silverstein clOd Gell, 1962; Janeway et al., 1975 Janeway et al., , 1976a  Levy and Shearer, 1982; Rao et a!., 1984) .
Although some studies (Simpson et al., 1978; Nagy and Elliot, 1979; Janeway et al., 1982) have indicated that alloreactive T-ct.lls are more cross reactive than self-MHC restricted T-cells, other studies (Melief et al., 1980; Sherman, 1982; DeWaal et al., 1983) with MHC mutants have suggested that this is due to the antigenic complexity of MHC molecules, rather than to a lack of specificity. In particular, studies at the clonal level have indicated that single amino acid substitutions can cause loss of recognition (Sherman, 1982) . Thus, alloreactive T cells are also capable of highly specific recognition of conformational nuances.
Another approach, based on limiting-dilution methcds, has also produced data that point to a high degree of T-cell multispecificity. It has been found that precursor T-cells specific for determinants on typical A (e.g. Strep. A, TNP and SRBC) occur at a frequency of about 1% (Eichmann et al., 1982; Fey et al., 1983) . Given the large diversity of As, this surprisingly high precursor frequency, which is substantially higher than B-cell precursor fre quencies, implies a high degree of multispecificity in T-cell A recognition.
How is it possible that T-cells can be precisely specific andmultispecific at the same time? Eich mann et al. (1982) have suggested that the apparent precision of T-cell antigen recognition seen in some studies is not due to intrinsic properties of the T-cell receptor, but is rather a property of populations of T-cells that arises as a result of regulation. This argument cannot be immediately excluded for earlier studies which assayed populations of cells. However, a substantial number of more recent studies which demonstrate precise recognition have employed T-cell clones. In these cases it is reason able to assume that the observed specificity is a reflection of the intrinsic specificity of the T-cell receptor. It thus appears that the simultaneous juxtaposition of precise specificity and multispeci ficity is a genuine paradox that must be resolved.
Our approach to resolving this paradox is based on the findings of Bevan (1981, 1982) , who have isolated clones having a dual specificity of the form Al + MHCl = A2 + MHC2. Cold target inhibition studies have shown that a single receptor recognizes both A-MHC combinations. If this dual specificity is interpreted in the context of a single recognition model, it becomes necessary to assume that the two A-MHC combinations generate neo epitopes that are cross-reactive relative to the single specificity of the receptor. Since little is currently known about the rules of neoepitope formation, it is difficult to pursue this line of interpretation further. However, if the dual specificity is interpreted in the context of a dual-recognition model, several import ant conclusions can be deduced. First, it might be expected that the dual specificity results from cross reactivity of Al and A2 relative to the anti-A site and cross-reactivity of MHCl and MHC2 relative to the anti-MHC site. Given the known multispecificity ofT-cells it is conceivable that Al or A2 could bind to the anti-A site in spite of a poor fit, or that the anti-A site contains distinct subsites that react with Al and A2. Similar expectations would also apply to the anti-MHC site. This explanation predicts that the cross-permutations Al + MHC2 and A2 + MHCl should also be recognized. However, Bevan (1981, 1982) have shown that they are not recognized. This rules out the "poor-fit" and "subsite" interpretations, and suggests that T-cell multispecificity cannot be equated with poor speci ficity.
The failure to recognize the cross-permutations also has additional implications for dual-recognition models. Classical dual-recognition models envision either separate anti-A and anti-MHC receptors or else independent sites on a single receptor. These models clearly predict that the cross-permutations described earlier should be recognized. That they are not seems to rule out these models. The firmness of this conclusion is further established by the findings of Kappler et al. (1981) . Using hybrid T cells having two distinct specificities (i.e. Al + simultaneously perturb the conformation of V, we write the induced complementarity state as V am ' which is an equilibrium conformational state that exists when the high-affinity ternary complex A:Vam:M is formed.
We now consider the reaction pathways that can lead to the formation of the high-affinity ternary complex. Because of the low probability that A and MHC will collide simultaneously with V, we assume that the formation of a ternary complex occurs in two steps, Either V first reacts with MHC and the binary complex thus formed reacts with A (pathway 1), or V first reacts with A and the resulting binary complex then reacts with MHC (pathway 2). We write pathway 1 as follows:
This pathway requires that Vom:M have moderate affinity for A. It is neither required nor excluded that V00 have moderate affinity for A.
Pathway 2 can be written as follows:
The requirements for pathway 2 are analogous to those of pathway 1.
Both pathways involve two conformational changes, one induced by A and the other induced by MHC, as required by postulate 2 which specifies that functional recognition of A requires the for mation of a high-affinity ternary complex.
COOPERATIVITY AS THE BASIS FOR FINE SPECIFICITY
At this point we are in a position to discuss the role of cooperativity in the binding of A and MHC molecules to V-molecules. Consider pathway 1: MHC binds to V and generates an intermediate complementarity state which has moderate affinity for A. The binding of A to the intermediate complex is assumed to induce a second conformational change. This conformational change can affect the affinity of V for MHC in three possible ways: (1) the affinity for MHC is not significantly changed, (2) the affinity for MHC is reduced (negative cooper ativity), or (3) the affinity for MHC is increased (positive cooperativity). These possibilities point to the requirement of positive cooperativity as a basis for explaining the exquisite specificity of T-cell antigen recognition. Conceivably, there could exist a number of A determinants which might bind to the intermediate complex with moderate affinity. Only those determinants which induce a conformational change which increases the binding of V to both MHC and A will lead to a high-affinity ternary complex which is capable of triggering the cell. Equation (3) describes this type of conformational change. It is clear that the requirement for positive cooperativity in the binding of A and MHC to V is a device which increases specificity. We suggest that positive cooperativity is the basis for the exquisite specificity of T-cell antigen recognition. We propose that this finding is an example of a general principle of multispecificity that applies to A recognition by MHC-restricted T-cells under physiological conditions. In particular, we propose that, within an organism, MHC determinants can be grouped into families of variant determinants such that, within a family, the variants are cross-reactive at the level of binary complexes but are sufficiently different in structure to differentially perturb the V molecules with which they form binary complexes. These different perturbations lead to different anti A specificities, thus accounting for the apparent multispecificity of T cells. This explanation of multispecificity requires that V-molecules possess multiple complementarity states and that MHC molecule determinants can be grouped into families of cross-reactive variants.
POSSffiLE ORIGINS OF MHC DETERMINANT FAMILIES
The well-known polymorphism of MHC loci generates a diversity of MHC molecules within the species. However, within a single organism, MHC encoded molecules that function as restriction el ements appear to be homogeneous at the level of amino acid sequence (Steinmetz and Hood, 1983) . It is therefore necessary to rationalize the existence of families of structurally different MHC determinants in an individual as specified earlier. We consider that MHC determinant families can arise in four ways.
(1) Carbohydrate microheterogeneity Evidence exists that a protein conformation on a human MHC molecule, as recognized by a mono clonal antibody, is greatly perturbed by removal of carbohydrate side chains . Moreover, tunicamycin treatment of virally infected target cells led to a 50% reduction of virus-specific CTL killing (Black et ai., 1981) . In another study (Gilmer et al., 1984) , a wheat germ agglutinin resistant variant of the EL-4 cell line was found to have unsialyated H-2K molecules. The fact that this variant would no longer grow in the peritoneal cavity of a syngeneic mouse suggested that absence of sialic acid made some determinants of the H-2K molecule appear foreign to syngeneic T-cells. Micro-. heterogeneity in the carbohydrate chains coJild generate a heterogeneity of perturbations, creating determinants that are variants of each other. Con ceivably, the variant determinants would be suf ficiently different to generate different Vom:M intermediate states leading to different functional specificities for A molecules. Evidence for the existence of carbohydrate microheterogeneity in Class II MHC molecules has been presented by at least two different laboratories (Freed and Nathen son, 1977; Quill and Schwartz, 1984) .
(2) Internal-sequence homology in MHC molecules
Recently, Ohno et al. (1982) have shown that Class I MHC molecules contain internal-sequence homology. In particular, comparison of amino acid sequences of the first three domains indicates that the second and first (amino terminal) domains are progressively diversified copies of the third domain, which is the most conserved one. Since these domains are approximate copies of each other, it is reasonable to expect that some determinants in one domain may be sufficiently similar to corresponding determinants in another domain to be cross-reactive at the level of binary V:M complexes. Conceivably, the Class· II MHC molecules which function as restriction elements also possess similar internal sequence homology.
(3) Cross-reaction among different Class I restricting elements and among different Class II restricting elements
Hiinig and Bevan have shown that a single clone can recognize two different A-MHC pairs, in which one MHC molecule is self and the other is allo. MHC molecules from two different haplotypes typically possess about 80% sequence homology in the domains thought to be recognized by T-cells (Steinmetz and Hood, 1983) . Since H-2K and H-2D within a single haplotype possess similar sequence homology, we might expect that a particular clone could recognize one antigen in association with H 2K, another in association with H-2D, and possibly a third antigen in association with H-2L, when it is present. Since these molecules have been shown to be cross-reactive at a serological level (Murphy and Shreffler, 1975) it is not unreasonable that they be cross-reactive as allosteric effectors at the level of binary complexes. Similar arguments might also apply to Class II restricting elements, since I-A and I-E molecules have been observed to cross-react at the level of alloreactive T-cells (Vucak et al., 1982) .
In FI-animals, the occurrence of cross-reactions (binary level) among determinants on MHC mol ecules of different haplotypes is also a possibility. That such cross-reactions can occur is supported by the findings of Hiinig and Bevan (AI + self MHC = A2 + allo MHC) and by the phenomenon of "aberrant recognition" in which normal splenic or thymic T-cells rigorously depleted of alloreactive cells are found to recognize conventional antigens in the context of allo MHC (Wilson et al., 1977; Doherty and Bennick, 1979; Stockinger et al., 1981) .
(4) Allostery of MHC molecules
A tacit assumption underlying the discussion thus far is that the A and MHC molecules are rigid structures which have conformations that are pre served when they interact with V-molecules. Given the enormous diversity of A molecules, exceptions to this assumption may exist but it is unlikely that they will be a typical occurrence. However, in the case of MHC molecules, there is recent evidence that multiple conformations may be a regular feature of these molecules. First, sequence data show that the Class I ctrdomain and the Class II ctl and 131-domains lack intradomain disulfide bonds, suggesting that these domains may possess flexi bility. Secondly, pairs of monoclonal antibodies have been isolated which mutually enhance binding. This has been found for both Class I and Class II MHC molecules, using Fab fragments in some cases (Diamond et al., 1984; Lemmonier et al., 1984 , and references therein). These findings have been inter preted as evidence of conformational flexibility. This raises the possibility that interactions between V and MHC may lead not only to conformational changes in V-molecules but also to conformational changes in MHC molecules. The different con formations of MHC molecules should generate sets of cross-reactive variant determinants. In the event that families of MHC determinants are generated in this fashion, the reaction mechanisms described previously would have to be modified to include conformational changes in MHC molecules, but the basic steps in the two pathways would be essentially as described. If transitions between conformational states in MHC molecules play a role in T-cell antigen recognition, then it should be possible to find anti-MHC antibodies that enhance A-recog nition. Very recently, monoclonal anti-HLA-DR antibodies that enhance the proliferative responses of A-specific T-cell Clones have been described (Triebel et al., 1984) .
PRECEDENTS FOR MULTIPLE COMPLEMENTARITY STATES
Our proposal that the T-cell receptor can assume multiple conformational states with multiple speci ficities has precedent in the field of enzymology. Of special interest in this connection are allosteric enzymes. Such enzymes fail to obey the Michaelis Menten kinetics that is predicted by a "Iock-and key" model (Koshland, 1958) and their behavior has been interpreted in terms of models which assume that these enzymes are capable of existing in multiple conformational states and that transitions between states occur as a result of interactions with ligands. Detailed theoretical models have been proposed [reviewed by Koshland and Neet (1968) ].
An example of a well-studied multistate enzyme is ribonucleotide reductase from E. coli. It has been found that allosteric effectors can bind at four sites (Thelander and Reichard, 1979) . Two identical sites control the overall activity; two other identical sites control specificity for substrate. Of special interest is the fact that the latter two sites can be occupied by four different effectors. Moreover, the specificity of the enzyme for the four different substrates (CDP, UDP, GDP and ADP) depends, in a parametric fashion, on the nature of effector ligands. Recent studies have shown that the Ly2 and UT4 molecules playa role in antigen recognition by T cells (Nakayama et al., 1979; Shinohara and Sachs, 1979; Swain et al., 1984) . In the case of the Ly2 molecule, available data suggest that this molecule enhances the affinity of antigen binding, being essential when the T-cell receptor has a borderline affinity for antigen, but -not when the receptor has an intrinsically high affinity. This picture has emerged from studies in which anti-Ly2 antibodies have been shown to inhibit target cell binding of some but not all clones (MacDonald et al., 1982) . We take these findings as evidence for the possible existence of a third allosteric site on the Class I restricted T-cell receptor which can bind Ly2. On the basis of the low polymorphism of the Ly2 antigen, we expect the binding site for Ly2 to have an invariant amino acid sequence and therefore to be in the constant region of the receptor molecule. In analogy with the interaction of C1q and immuno globulin, we further expect that the formation of an antigen-T-cell receptor complex will create a per turbed Ly2 binding site that binds Ly2 with in creased affinity, leading to a more stable complex.
In the case of murine Class II restricted T-cells, the L3T4 antigen may be analogous to th.: Ly2 antigen since a monoclonal anti-UT4 antibody has been found to inhibit antigen binding but to different degrees with different clones (Swain et at., 1984) .
Another interesting possibility is that the Mis antigen (Festenstein, 1973) , present on B-cells and macrophages, may also function as an affinity enhancing allosteric effector of Class II restricted T cells. The fact that allotypic forms of the Mis antigen can stimulate an even greater fraction of precursors than the MHC antigen of a foreign ha.ptotype (Janeway et ai., 1980; Lutz et ai., 1981) is consistent with the possibility that all Class II restricted T-cell receptors have an anti-Mis site. In the syngeneic case, we expect that the Mis antigen will have a subthreshold affinity for V00 (Molnar-Kimber and Sprent, 1983) or Vom:M . The formation of the complete A:Vam:M complex is expected to create a perturbed Mis-binding site which will recognize the Mis antigen with function ally significant affinity, leading to stabilization of the complex as a whole.
Another molecule of low polymorphism, which may function as an allosteric effector of the T-cell receptor is the T3 antigen. This antigen is found on all human T-cells and appears to be associated with clonotypic structures (Reinherz et ai., 1983) .
ASYMMETRIC ANTIBODY INHIBITION OF T-CELL A RECOGNITION: INTERPRETATION IN THE CONTEXT OF THE MULTISTATE ALLOSTERIC RECEPTOR MODEL
One of the more puzzling aspects of MHC restricted T-cell A recognition is the differential ability of anti-A and anti-MHC antibodies to inhibit A recognition. In general, anti-A antibodies have been found to be weak inhibitors, whereas inhibition with anti-MHC antibodies has been easily achieved. This has been found for both Class I and Class II restricted T-cells (Askonas and Webster, 1980; Finberg and Benacerraf, 1981; Zinkernagel and Rosenthal, 1981) . A possible explanation of this phenomenon in the context of the multistate allo steric receptor model can be derived from an inspection of the reaction pathways that can lead to formation of the high-affinity ternary complex (discussed earlier). Antibodies could inhibit T-cell recognition by competing with the high-affinity A:V:M complex or by preventing the formation of the binary A:V or V:M complexes, which are of only moderate affinity. If the A:V:M complex is of sufficiently high affinity to make direct antibody competition unlikely, then antibody inhibition would have to occur by inhibiting formation of binary complexes. For pathway 1, only anti-MHC antibodies would be effective, and, for pathway 2, only anti-A antibodies would be effective. That only anti-MHC antibodies are efficient inhibitors is consistent with the possibility that only pathway 1 leads to the formation of high-affinity ternary . complexes.
CONCLUSION
The remarkable findings of Hiinig and Bevan, Kappler, Harris, and their respective coworkers, have led to the conclusion that dual-recognition models with independent anti-A and anti-MHC sites are untenable. This has in turn led to the view, by others, that single-recognition or altered-self models are the remaining viable alternative. We have tried to demonstrate that dual-recognition models with interacting anti-A and anti-MHC sites can be con sistent with these findings. The notion that the sites interact with each other leads naturally to an allosteric receptor model. We further demonstrate that paradoxical aspects of T-cell antigen specificity as well as the phenomenon of MHC restriction can be accommodated in the context of a multistate allosteric receptor model that has as precedents certain findings established for allosteric enzymes.
